Advertisement
Correspondence and communication| Volume 65, ISSUE 7, P986-987, July 2012

Classification of Raynaud’s disease based on angiographic features: Rationalising treatment

Published:February 16, 2012DOI:https://doi.org/10.1016/j.bjps.2012.01.016
      We thank Dr Dariush Nikkhah and his co-authors for their interest in our article entitled ‘Classification of Raynaud’s disease based on angiographic features’.
      • Kim Y.H.
      • Ng S.W.
      • Seo H.S.
      • Chang Ahn H.
      Classification of Raynaud’s disease based on angiographic features.
      They have suggested including botulinum therapy in the treatment algorithm for chronic intractable ischaemic digits resulting from Raynaud’s disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kim Y.H.
        • Ng S.W.
        • Seo H.S.
        • Chang Ahn H.
        Classification of Raynaud’s disease based on angiographic features.
        J Plast Reconstruct Aesthet Surg. 2011; 64: 1503-1511
        • Sycha T.
        • Graninger E.
        • Auff E.
        • Schnider P.
        Botulinum toxin in the treatment of Raynaud’s phenomenon: a pilot study.
        Eur J Clin Invest. 2004; 34: 312
        • Van Beek A.L.
        • Lim P.K.
        • Gear A.J.L.
        • Pritzker M.R.
        Management of vasospastic disorders with botulinum toxin A.
        Plast Reconstr Surg. 2007; 119: 217
        • Neumeister M.W.
        • Chambers C.B.
        • Herron M.S.
        • et al.
        Botox therapy for ischemic digits.
        Plast Reconstr Surg. 2009; 124: 191-201
        • Fregene A.
        • Ditmars D.
        • Siddiqui A.
        Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud’s phenomenon.
        J Hand Surg Am. 2009; 2009: 446-452

      Linked Article

      • Rationalising treatment of Raynaud’s syndrome
        Journal of Plastic, Reconstructive & Aesthetic SurgeryVol. 65Issue 7
        • Preview
          We read with great interest the article entitled ‘Classification of Raynaud’s disease based on angiographic features.’1 We congratulate the authors for attempting to rationalise their previous surgical practice in managing digital ischaemia in the hand into a treatment-oriented classification. Whilst we believe that this approach may improve the treatment of patients with symptoms refractory to medical measures, we believe that the algorithm is incomplete, and not adequately justified.
        • Full-Text
        • PDF